MedTrace Logo

Negative Antiphospholipid Syndrome: a Multicentric Study

NCT06373003 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-05-14

No results posted yet for this study

Summary

Multicentre no-profit, national, (cross-sectional diagnostic) retrospective study, promoted by the Italian Society for Rheumatology.

The main objective of the study is to assess the diagnostic accuracy of non-criteria aPL (anti-vimentin/cardiolipin and anti-phosphatidylserine/prothrombin) in identifying APS in patients with thrombosis/recurrent adverse pregnancy outcomes.

Conditions

  • Antiphospholipid Syndrome
  • Seronegative Antiphospholipid Syndrome

Interventions

OTHER

Diagnostic accuracy

To assess the diagnostic accuracy of non-criteria aPL (anti-vimentin/cardiolipin and anti-phosphatidylserine/prothrombin) in identifying APS in patients with thrombosis/ recurrent adverse pregnancy outcomes

Sponsors & Collaborators

  • Italian Society for Rheumatology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-21
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06373003 on ClinicalTrials.gov